DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF.

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

Cardiovascular Disease In CKD: Is It for Children
Christopher Keller, MD Director of Clinical Operations Boise Kidney and Hypertension Institute RPA 2011 Annual Meeting Friday, March 18, 2011.
HLA TYPING D Middleton MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF THE RUSSELL GROUP.
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
ESAs and Outcomes in CKD Patients Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010.
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Regional Transplant Forum Sept Current national format NHSBT Kidney Advisory Group Renal Transplant Clinical Reference Group NHS England BTS Guidelines.
“Yes Minister, we can deliver cheaper kidney care” Lisa Burnapp Lead Nurse-Living Donation, NHS Blood & Transplant Consultant Nurse-Living Donor Kidney.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
CKD and Exercise 中國醫藥大學北港附設醫院 復健科主任 陳信水. CKD associated physical dysfunction Muscle wasting Weight loss Excessive fatigue Sexual dysfunction Uremic myopathy.
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
Widening the Circles of Inclusion The National Renal Service Dr Donal O’Donoghue Co-Chair Renal Advisory Group 4 July 2006.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
ETHNIC DISPARITIES IN KIDNEY TRANSPLANTATION: REPLACEMENT OF RENAL FUNCTION IN ROMA („GYPSIE“) MINORITY IN CROATIA Milica Kljak University Hospital Centre.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Interactive Case Discussion Case 6 Dr Megha S Uppin Asst Prof Dept of Pathology Nizam’s Institute of Medical Sciences Hyderabad.
Review of literature and report of experience with erythropoietin in ESRD populations Summary to FDA Cardio Renal Committee J. Michael Lazarus, M.D. CMO.
Vascular access for haemodialysis in Scotland Andrew Henderson, Keith Simpson, Gordon Prescott, Joanne Boyd and Alison Severn, on behalf of the Scottish.
Healthy People 2010 Focus Area 4
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
Graham Lipkin September 23 rd 2014 West Midlands Renal Network Transplant Education & Audit.
Obesity in kidney transplantation…. Dan Ridgway, Consultant Surgeon, Royal Liverpool University Hospital.
1 Antonio Bellasi, MD Medical manager Genzyme, Italy Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD)
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
The FAVORIT Study (Folic Acid for Vascular Outcome Reduction in Transplantation) Source Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering.
World Kidney Day 2016: Kidney Disease & Children
2016 Annual Data Report, Vol 2, ESRD, Ch 6
A.M. Thompson, T.G. Pickering  Kidney International 
UK Renal Registry 10th Annual Report 2007
Section 3: CKD, CVD and mortality
UK Renal Registry 15th Annual Report
Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /
Benefits of Renal Transplantation over Dialysis
Fan et al. Am J Nephrol 2017;45:   (DOI: / )
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Jayant A. Talwalkar, MD, MPH, Patrick S. Kamath, MD 
Increased Levels of Tumor Necrosis Factor α Are Associated with an Increased Risk of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
S. Sagedal, A. Hartmann, H. Rollag  Clinical Microbiology and Infection 
UK Renal Registry 13th Annual Report
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Volume 68, Issue 5, Pages (November 2005)
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.
(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.
JAMA Internal Medicine 2018;178(11):
Does equal care give equal outcomes?
Kaplan-Meier curve of cumulative percentage of cardiac mortality by peak flow rate category (adjusted HRs (95% CI) compared with ≥550 L/min: (
Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease  Sandra Amaral, Blayne A.
Representative Light Micrographs of Kidney Sections Illustrating the Histologic Scoring Criteria Giuseppe Remuzzi, et al, N Engl J Med 2006;3354:
Kaplan-Meier curves for the end point all-cause mortality in the total patient population stratified according to complete/incomplete revascularisation.
Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.
Cumulative survival curves for deceased-donor transplant recipients who were older than 70 yr and similarly aged dialysis patients who were on the waiting.
Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.
(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.
Presentation transcript:

DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF THE RUSSELL GROUP CONTINUING PROFESSIONAL DEVELOPMENT

2 Dialysis or Transplantation Benefits of Transplantation Survival Quality of life Cost- effectiveness

3 Dialysis or Transplantation CKD ESRD & Dialysis TransplantationDeath Death Death Death DeathDeath Death Death

4 Dialysis or Transplantation Survival Dialysis Transplantation NHSBT data file

5 Dialysis or Transplantation Survival Gill et al Kidney Int 2005 Mortality rate on the waiting list (per 100 patient years)

6 Dialysis or Transplantation Survival Kaplan-Meier survival estimate for kidney transplant recipients versus pts on waiting list on HD Johnson et al A comparison of the effects of dialysis and renal transplantation on the survival of older uraemic patients. Transplantation 69: ,2000

7 Dialysis or Transplantation Survival Ojo, J Am Soc Neph, 2001;12:589

8 Dialysis or Transplantation Survival Foley, Am J Kidney Dis, 1998;32(S1):8 Cardiovascular effect of renal transplantation

9 Dialysis or Transplantation Quality of Life Many studies demonstrated better quality of life after transplantation compared to dialysis. Life satisfaction, physical, emotional well-being and ability to return to work are higher in transplant recipients. Most of uremic complications are fully reversed. Fertility and sexual function may return. Adapted from Danovitch, Handbook of Kidney Transplantation, Lippincott Williams & Wilkins, 5 th Edition

10 Dialysis or Transplantation Cost Effectiveness: UK Model Increased rates of return to work Cost of therapy The average cost of dialysis is £30,800 per patient per year The cost of a kidney transplant (including induction therapy but excluding NHSBT costs) is £17,000 per patient per transplant The immunosuppression required by a patient with a transplant costs £5,000 per patient per year Kidney transplantation leads to a cost benefit in the second and subsequent years of £25,800 pa. NHSBT data files, UK

11 Dialysis or Transplantation Cost Effectiveness: US Model Cost to society: Annual cost of hemodialysis: $60,000-$80,000 First year after transplantation: around $100,000 Thereafter: $10,000 per year Mean cumulative costs of dialysis and transplantation are equal for first 3-4 years, then lower for transplantation. Adapted from Danovitch, Handbook of Kidney Transplantation, Lippincott Williams & Wilkins, 5 th Edition

12 Dialysis or Transplantation Transplantation Dialysis

13 Dialysis or Transplantation When to do the Transplant? Herwig-Ulf meier-Kriesche and Bruce Kaplan, Transplantation vol. 74, 1377– 1381, no. 10, November 27, 2002, Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes Analysis of 2,405 recipients of paired donor kidneys

14 Dialysis or Transplantation

15 Dialysis or Transplantation References NHSBT Gill et al, Kidney Int Johnson et al, 2000, Transplantation 69: Ojo, J Am Soc Neph, 2001;12:589 Foley, Am J Kidney Dis, 1998;32(S1):8 Danovitch, Handbook of Kidney Transplantation, Lippincott Williams & Wilkins, 5 th Edition Kriesche and Bruce Kaplan, 2002, Transplantation vol. 74 (10), 1377–1381

A MEMBER OF THE RUSSELL GROUP FACULTY OF HEALTH & LIFE SCIENCES – CPD Institute for Learning & Teaching Faculty of Health & Life Sciences Room 2.16A, 4th Floor Thompson Yates Building Brownlow Hill Liverpool L69 3GB